AbbVie
ABBV
#57
Rank
$203.80 B
Marketcap
$115.28
Share price
-1.38%
Change (1 day)
11.94%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: $203.80 Billion

As of November 2021 AbbVie has a market cap of $203.80 Billion. This makes AbbVie the world's 57th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of AbbVie from 2012 to 2021

Year Market cap Change
2021$205.97 B8.88%
2020$189.17 B44.47%
2019$130.94 B-3.95%
2018$136.33 B-11.7%
2017$154.39 B51.71%
2016$101.76 B6.7%
2015$95.37 B-8.42%
2014$104.14 B24.23%
2013$83.82 B55.32%
2012$53.97 B

End of Day market cap according to different sources

On Nov 29th, 2021 the market cap of AbbVie was reported to be:

$206.64 Billion
by Yahoo Finance
$206.64 Billion
by CompaniesMarketCap
$205.97 Billion
by Reuters
$206.64 Billion
by Nasdaq
$206.56 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap difference Country
$301.57 B 47.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$237.27 B 16.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$112.02 B-45.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$34.62 B-83.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$86.46 B-57.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$119.03 B-41.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$170.72 B-16.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
$103.45 B-49.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
$7.89 B-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA